Loomis, Sayles & Company’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.2M Buy
2,148,864
+42,796
+2% +$821K 0.06% 111
2026
Q1
$37.1M Sell
2,106,068
-129,990
-6% -$2.61M 0.05% 135
2025
Q4
$44.2M Buy
+2,236,058
New +$40.2M 0.05% 115
2023
Q2
Sell
-1,523,531
Closed -$9.69M 970
2023
Q1
$9.69M Sell
1,523,531
-355,071
-19% -$3.39M 0.02% 335
2022
Q4
$22.1M Buy
1,878,602
+341,170
+22% +$4.15M 0.04% 214
2022
Q3
$18.2M Buy
+1,537,432
New +$22.4M 0.04% 222

Other funds holding ALHC

Loomis, Sayles & Company's ALHC Position: Q2 2026 in Review

Loomis, Sayles & Company increased its Alignment Healthcare (ALHC) stake by 2% in Q2 2026, buying an estimated $821K and bringing the position to 2,148,864 shares worth $51.2M. The position accounts for 0.06% of the portfolio, ranked #111.

Loomis, Sayles & Company first reported a position in ALHC in Q3 2022 and has held it in 6 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Loomis, Sayles & Company held 2,148,864 shares of Alignment Healthcare worth $51.2M as of Q2 2026.
  • Loomis, Sayles & Company bought 42,796 Alignment Healthcare shares in Q2 2026, an estimated $821K.
  • Alignment Healthcare made up 0.06% of Loomis, Sayles & Company's portfolio in Q2 2026, its #111 holding.
  • Loomis, Sayles & Company first reported a position in Alignment Healthcare in Q3 2022 and has held it in 6 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.